AAAAAA

   
Results: 1-16 |
Results: 16
METABOLISM OF ROPIVACAINE IN HUMANS IS MEDIATED BY CYP1A2 AND TO A MINOR EXTENT BY CYP3A4 - AN INTERACTION STUDY WITH FLUVOXAMINE AND KETOCONAZOLE AS IN-VIVO INHIBITORS
Authors: ARLANDER E EKSTROM G ALM C CARRILLO JA BIELENSTEIN M BOTTIGER Y BERTILSSON L GUSTAFSSON LL
Citation: E. Arlander et al., METABOLISM OF ROPIVACAINE IN HUMANS IS MEDIATED BY CYP1A2 AND TO A MINOR EXTENT BY CYP3A4 - AN INTERACTION STUDY WITH FLUVOXAMINE AND KETOCONAZOLE AS IN-VIVO INHIBITORS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 484-491
BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE
Authors: HERRLIN K MASSELE AY JANDE M ALM C TYBRING G ABDI YA WENNERHOLM A JOHANSSON I DAHL ML BERTILSSON L GUSTAFSSON LL
Citation: K. Herrlin et al., BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 391-401
IN-VITRO AND IN-VIVO STUDIES ON THE DISPOSITION OF MIRTAZAPINE IN HUMANS
Authors: DAHL ML VOORTMAN G ALM C ELWIN CE DELBRESSINE L VOS R BOGAARDS JJP BERTILSSON L
Citation: Ml. Dahl et al., IN-VITRO AND IN-VIVO STUDIES ON THE DISPOSITION OF MIRTAZAPINE IN HUMANS, Clinical drug investigation, 13(1), 1997, pp. 37-46
INTRAGASTRIC PH AFTER ORAL-ADMINISTRATION OF SINGLE DOSES OF RANITIDINE EFFERVESCENT TABLETS, OMEPRAZOLE CAPSULES AND FAMOTIDINE FAST-DISSOLVING TABLETS TO FASTING HEALTHY-VOLUNTEERS
Authors: HEDENSTROM H ALM C KRAFT M GRAHNEN A
Citation: H. Hedenstrom et al., INTRAGASTRIC PH AFTER ORAL-ADMINISTRATION OF SINGLE DOSES OF RANITIDINE EFFERVESCENT TABLETS, OMEPRAZOLE CAPSULES AND FAMOTIDINE FAST-DISSOLVING TABLETS TO FASTING HEALTHY-VOLUNTEERS, Alimentary pharmacology & therapeutics, 11(6), 1997, pp. 1137-1141
QUANTIFICATION OF THE O-DEMETHYLATED AND N-DEMETHYLATED AND THE GLUCURONIDATED METABOLITES OF CODEINE RELATIVE TO THE DEBRISOQUINE METABOLIC RATIO IN URINE IN ULTRARAPID, RAPID, AND POOR DEBRISOQUINE HYDROXYLATORS
Authors: YUE QY ALM C SVENSSON JO SAWE J
Citation: Qy. Yue et al., QUANTIFICATION OF THE O-DEMETHYLATED AND N-DEMETHYLATED AND THE GLUCURONIDATED METABOLITES OF CODEINE RELATIVE TO THE DEBRISOQUINE METABOLIC RATIO IN URINE IN ULTRARAPID, RAPID, AND POOR DEBRISOQUINE HYDROXYLATORS, Therapeutic drug monitoring, 19(5), 1997, pp. 539-542
INTRAINDIVIDUAL AND INTERINDIVIDUAL VARIABILITY IN THE DISPOSITION OFTHE LOCAL-ANESTHETIC ROPIVACAINE IN HEALTHY-SUBJECTS
Authors: EMANUELSSON BM PERSSON J SANDIN S ALM C GUSTAFSSON LL
Citation: Bm. Emanuelsson et al., INTRAINDIVIDUAL AND INTERINDIVIDUAL VARIABILITY IN THE DISPOSITION OFTHE LOCAL-ANESTHETIC ROPIVACAINE IN HEALTHY-SUBJECTS, Therapeutic drug monitoring, 19(2), 1997, pp. 126-131
SYSTEMIC ABSORPTION AND BLOCK AFTER EPIDURAL INJECTION OF ROPIVACAINEIN HEALTHY-VOLUNTEERS
Authors: EMANUELSSON BMK PERSSON J ALM C HELLER A GUSTAFSSON LL
Citation: Bmk. Emanuelsson et al., SYSTEMIC ABSORPTION AND BLOCK AFTER EPIDURAL INJECTION OF ROPIVACAINEIN HEALTHY-VOLUNTEERS, Anesthesiology, 87(6), 1997, pp. 1309-1317
INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS
Authors: BOTTIGER Y DOSTERT P BENEDETTI MS BANI M FIORENTINI F CASATI M POGGESTI I ALM C ALVAN G BERTILSSON L
Citation: Y. Bottiger et al., INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS, British journal of clinical pharmacology, 42(6), 1996, pp. 707-711
MONITORING FREE EXTRACELLULAR VALPROIC ACID BY MICRODIALYSIS IN EPILEPTIC PATIENTS
Authors: STAHLE L ALM C EKQUIST B LUNDQUIST B TOMSON T
Citation: L. Stahle et al., MONITORING FREE EXTRACELLULAR VALPROIC ACID BY MICRODIALYSIS IN EPILEPTIC PATIENTS, Therapeutic drug monitoring, 18(1), 1996, pp. 14-18
DISPOSITION OF FLUVOXAMINE IN HUMANS IS DETERMINED BY THE POLYMORPHICCYP2D6 AND ALSO BY THE CYP1A2 ACTIVITY
Authors: CARRILLO JA DAHL ML SVENSSON JO ALM C RODRIGUEZ I BERTILSSON L
Citation: Ja. Carrillo et al., DISPOSITION OF FLUVOXAMINE IN HUMANS IS DETERMINED BY THE POLYMORPHICCYP2D6 AND ALSO BY THE CYP1A2 ACTIVITY, Clinical pharmacology and therapeutics, 60(2), 1996, pp. 183-190
QUALITY OF CHLOROQUINE PREPARATIONS MARKETED IN DAR-ES-SALAAM, TANZANIA
Authors: ABDI YA RIMOY G ERICSSON O ALM C MASSELE AY
Citation: Ya. Abdi et al., QUALITY OF CHLOROQUINE PREPARATIONS MARKETED IN DAR-ES-SALAAM, TANZANIA, Lancet, 346(8983), 1995, pp. 1161-1161
CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST
Authors: BERTILSSON L CARRILLO JA DAHL ML LLERENA A ALM C BONDESSON U LINDSTROM L DELARUBIA IR RAMOS S BENITEZ J
Citation: L. Bertilsson et al., CLOZAPINE DISPOSITION COVARIES WITH CYP1A2 ACTIVITY DETERMINED BY A CAFFEINE TEST, British journal of clinical pharmacology, 38(5), 1994, pp. 471-473
STEREOSELECTIVE DISPOSITION OF MIANSERIN IS RELATED TO DEBRISOQUIN HYDROXYLATION POLYMORPHISM
Authors: DAHL ML TYBRING G ELWIN CE ALM C ANDREASSON K GYLLENPALM M BERTILSSON L
Citation: Ml. Dahl et al., STEREOSELECTIVE DISPOSITION OF MIANSERIN IS RELATED TO DEBRISOQUIN HYDROXYLATION POLYMORPHISM, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 176-183
PHARMACOKINETICS OF ROPIVACAINE AFTER 3 IV DOSES
Authors: PERSSON J ALM C MAGNUSSON A GUSTAFSSON LG
Citation: J. Persson et al., PHARMACOKINETICS OF ROPIVACAINE AFTER 3 IV DOSES, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 123-123
POLYMORPHIC 2-HYDROXYLATION OF DESIPRAMINE - A POPULATION AND FAMILY STUDY
Authors: DAHL ML ISELIUS L ALM C SVENSSON JO LEE D JOHANSSON I INGELMANSUNDBERG M SJOQVIST F
Citation: Ml. Dahl et al., POLYMORPHIC 2-HYDROXYLATION OF DESIPRAMINE - A POPULATION AND FAMILY STUDY, European Journal of Clinical Pharmacology, 44(5), 1993, pp. 445-450
HALOPERIDOL DISPOSITION IS DEPENDENT ON DEBRISOQUINE HYDROXYLATION PHENOTYPE
Authors: LLERENA A ALM C DAHL ML EKQVIST B BERTILSSON L
Citation: A. Llerena et al., HALOPERIDOL DISPOSITION IS DEPENDENT ON DEBRISOQUINE HYDROXYLATION PHENOTYPE, Therapeutic drug monitoring, 14(2), 1992, pp. 92-97
Risultati: 1-16 |